NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-045-2021-0-US-02 NOVEL COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE US National Stage 18/277,921 Pending
NIAMS E-244-2020-0-AU-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 AU National Stage 2022224636 Issued
NCI E-239-2017-0-JP-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS JP DIV 2023-133670 Pending
NIAMS E-244-2020-0-CA-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 CA National Stage 3209052 Issued
NEI E-013-2021-0-CN-02 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE CN National Stage 202180094031.6 Pending
NCI E-078-2012-0-CA-01 Anti-Mesothelin Chimeric Antigen Receptors CA DIV 3209571 Pending
NIAMS E-244-2020-0-IL-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 IL National Stage 305301 Issued
NIAID E-240-2023-0-EP-01 VACCINES AGAINST CORONAVIRUSES EP ORD 23315318.8 Pending
NCI E-174-2022-0-PC-01 Synergistic Interactions For Improved Cancer Treatment PCT PCT PCT/US2023/072333 Pending
NCI E-029-2021-0-US-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 US National Stage 18/277,521 Pending
NHLBI E-134-2022-0-PC-01 SYSTEMS AND METHODS FOR ELECTROCARDIOGRAPHIC RADIAL DEPTH
NAVIGATION OF INTRACARDIAC DEVICES 		PCT PCT PCT/US2023/072161 Pending
NEI E-192-2014-1-US-01 Surgical Tool And Method For Soft Ocular Tissue Transplantation US CON 18/233,654 Pending
NIAID E-214-2021-2-US-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides US National Stage 18/277,220 Pending
NIAID E-055-2021-0-KR-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use KR National Stage 10-2023-7027608 Pending
NIAID E-140-2022-0-PC-01 Dual-Germline Antibody Engager HIV-1 Envelope Chimeric Immunogens PCT PCT PCT/US2023/072123 Pending
NIAID E-214-2021-2-CA-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides CA National Stage 3207998 Pending
NCI E-029-2021-0-CA-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 CA National Stage 3207989 Pending
NIAID E-214-2021-2-MX-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides MX National Stage MX/A/2023/009417 Pending
NCI E-169-2024-0-US-01 LNA Gapmers Inhibit Growth of Pancreatic Cancer US 63/531,993 Expired
NIAID E-191-2023-0-US-02 METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS US National Stage 18/276,599 Pending
NCI E-256-2020-0-EP-01 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS 		EP National Stage 22705222.2 Pending
NCI E-243-2020-0-EP-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER EP National Stage 22705630.6 Pending
NIAID E-037-2021-1-JP-10 Antibodies Targeting The Spike Protein Of Coronaviruses JP National Stage 2023-547766 Pending
NIA E-151-2022-0-PC-01 HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE PCT PCT PCT/US2023/029602 Pending
NIDDK E-051-2021-0-EP-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS EP National Stage 22701105.3 Pending
NIAID E-052-2017-4-MY-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MY DIV PI 2023004262 Pending
NIAID E-037-2021-1-MX-12 Antibodies Targeting The Spike Protein Of Coronaviruses MX National Stage MX/a/2023/009244 Pending
NIAID E-037-2021-1-CL-05 Antibodies Targeting The Spike Protein Of Coronaviruses CL National Stage 202302326 Pending
NCI E-064-2021-0-US-02 Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection US National Stage 18/275,925 Pending
NEI E-094-2016-0-JP-01 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY JP DIV 2023-127909 Pending
NEI E-094-2016-0-JP-02 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY JP DIV 2023-127908 Pending
NIAID E-037-2021-1-IL-08 Antibodies Targeting The Spike Protein Of Coronaviruses IL National Stage 304955 Pending
NCATS E-232-2017-0-JP-01 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders JP DIV 2023-127334 Pending
NIAID E-038-2017-1-US-05 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US CON 18/364,104 Abandoned
NIAID E-037-2021-1-US-01 Antibodies Targeting The Spike Protein Of Coronaviruses US National Stage 18/263,995 Pending
NCI E-088-2023-0-US-01 DEVELOPMENT OF NOVEL ANTIBODIES AND SINGLE CHAIN VARIABLE FRAGMENTS AGAINST EXTRACELLULAR PRAME US 63/530,440 Expired
NIAID E-002-2023-1-US-01 VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS US 63/517,246 Expired
NIBIB E-157-2023-0-US-01 Rapid spectral unmixing using Spectrally Interpolated Background Reduction (SIBR) US 63/529,866 Expired
NIAID E-037-2021-1-BR-03 Antibodies Targeting The Spike Protein Of Coronaviruses BR National Stage BR112023015424-3 Pending
NIAID E-177-2022-0-PCT-02 Monoclonal Antibodies that bind to the underside of Influenza Viral Neuraminidase PCT PCT PCT/US2023/071194 Pending
NCI E-243-2020-0-US-02 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER US National Stage 18/263,394 Pending
NCI E-243-2020-0-JP-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER JP National Stage 2023-545802 Pending
NCI E-237-2017-2-JP-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 JP DIV 2023-123893 Pending
NCI E-243-2020-0-CA-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER CA National Stage 3210086 Pending
NIDA E-133-2022-0-PCT-01 SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS PCT PCT PCT/US2023/071022 Pending
NHLBI E-056-2021-0-US-02 A New Molecular Scaffold For Targeting HRpn13 US National Stage 18/262,941 Pending
NCI E-016-2018-0-US-02 CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS US DIV 18/359,071 Pending
NEI E-033-2021-0-EP-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF EP National Stage 21742557.8 Pending
NIAID E-154-2022-0-PC-01 METHOD OF IMMMUNOFOCUSING AN IMMUNE RESPONSE PCT PCT PCT/US2023/070926 Pending
NEI E-293-2016-0-US-02 TISSUE CLAMP AND IMPLANTATION METHOD US DIV 18/226,043 Pending